Advertisement

Topics

Sunovion???s Aptiom (Eslicarbazepine Acetate) Receives FDA Approval For Expanded Indication To Treat Partial-Onset Seizures In Children And Adolescents 4 Years Of Age And Older

20:00 EDT 14 Sep 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Sunovion???s Aptiom (Eslicarbazepine Acetate) Receives FDA Approval For Expanded Indication To Treat Partial-Onset Seizures In Children And Adolescents 4 Years Of Age And Older

NEXT ARTICLE

More From BioPortfolio on "Sunovion???s Aptiom (Eslicarbazepine Acetate) Receives FDA Approval For Expanded Indication To Treat Partial-Onset Seizures In Children And Adolescents 4 Years Of Age And Older"

Quick Search
Advertisement